Sökning: onr:"swepub:oai:DiVA.org:su-170819" > Disruption of the E...
Fältnamn | Indikatorer | Metadata |
---|---|---|
000 | 08899naa a2200877 4500 | |
001 | oai:DiVA.org:su-170819 | |
003 | SwePub | |
008 | 190730s2019 | |||||||||||000 ||eng| | |
009 | oai:lup.lub.lu.se:dd004f7d-31a5-4193-ac94-3f225200bc62 | |
009 | oai:DiVA.org:liu-158947 | |
009 | oai:prod.swepub.kib.ki.se:141247867 | |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-1708192 URI |
024 | 7 | a https://doi.org/10.1161/ATVBAHA.119.3123882 DOI |
024 | 7 | a https://lup.lub.lu.se/record/dd004f7d-31a5-4193-ac94-3f225200bc622 URI |
024 | 7 | a https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-1589472 URI |
024 | 7 | a http://kipublications.ki.se/Default.aspx?queryparsed=id:1412478672 URI |
040 | a (SwePub)sud (SwePub)lud (SwePub)liud (SwePub)ki | |
041 | a engb eng | |
042 | 9 SwePub | |
072 | 7 | a ref2 swepub-contenttype |
072 | 7 | a art2 swepub-publicationtype |
100 | 1 | a Jensen, Lasseu Linköpings universitet,Linköping University,Avdelningen för kardiovaskulär medicin,Medicinska fakulteten,Region Östergötland, Klinisk farmakologi4 aut0 (Swepub:liu)larje86 |
245 | 1 0 | a Disruption of the Extracellular Matrix Progressively Impairs Central Nervous System Vascular Maturation Downstream of beta-Catenin Signaling |
264 | 1 | b LIPPINCOTT WILLIAMS & WILKINS,c 2019 |
338 | a print2 rdacarrier | |
500 | a Funding Agencies|Cancerfonden [CAN 2010/679]; Karolinska Funding for Doctorial Studies; Swedish Society for Medical Research; Jeanssons Stiftelser; Swedish Research Council; H2020-MSCA-RISE (3D-NEONET); Johnson Johnson [K240001043]; Marie Curie FP7 people initiative Fellowship [626544]; National Institutes of Health [AR070748, AR53890]; Swedish Brain Foundation; Tore Nilsons Stiftelse; Tornspiran; Lars Hiertas Stiftelse; Jane Foundation; Dan Olsson Foundation; Samariten and Bergvalls Stiftelse | |
520 | a Objective- The Wnt/beta-catenin pathway orchestrates development of the blood-brain barrier, but the downstream mechanisms involved at different developmental windows and in different central nervous system (CNS) tissues have remained elusive. Approach and Results- Here, we create a new mouse model allowing spatiotemporal investigations of Wnt/beta-catenin signaling by induced overexpression of Axin1, an inhibitor of beta-catenin signaling, specifically in endothelial cells (Axin1(iEC)-(OE)). AOE (Axin1 overexpression) in Axin1(iEC)-(OE) mice at stages following the initial vascular invasion of the CNS did not impair angiogenesis but led to premature vascular regression followed by progressive dilation and inhibition of vascular maturation resulting in forebrain-specific hemorrhage 4 days post-AOE. Analysis of the temporal Wnt/beta-catenin driven CNS vascular development in zebrafish also suggested that Axin1(iEC)-(OE) led to CNS vascular regression and impaired maturation but not inhibition of ongoing angiogenesis within the CNS. Transcriptomic profiling of isolated, beta-catenin signaling-deficient endothelial cells during early blood-brain barrier-development (E11.5) revealed ECM (extracellular matrix) proteins as one of the most severely deregulated clusters. Among the 20 genes constituting the forebrain endothelial cell-specific response signature, 8 (Adamtsl2, Apod, Ctsw, Htra3, Pglyrp1, Spock2, Ttyh2, and Wfdc1) encoded bona fide ECM proteins. This specific beta-catenin-responsive ECM signature was also repressed in Axin1(iEC)-(OE) and endothelial cell-specific beta-catenin-knockout mice (Ctnnb1-KOiEC) during initial blood-brain barrier maturation (E14.5), consistent with an important role of Wnt/beta-catenin signaling in orchestrating the development of the forebrain vascular ECM. Conclusions- These results suggest a novel mechanism of establishing a CNS endothelium-specific ECM signature downstream of Wnt-beta-catenin that impact spatiotemporally on blood-brain barrier differentiation during forebrain vessel development. | |
650 | 7 | a NATURVETENSKAPx Biologi0 (SwePub)1062 hsv//swe |
650 | 7 | a NATURAL SCIENCESx Biological Sciences0 (SwePub)1062 hsv//eng |
650 | 7 | a MEDICIN OCH HÄLSOVETENSKAPx Medicinska och farmaceutiska grundvetenskaperx Cell- och molekylärbiologi0 (SwePub)301082 hsv//swe |
650 | 7 | a MEDICAL AND HEALTH SCIENCESx Basic Medicinex Cell and Molecular Biology0 (SwePub)301082 hsv//eng |
653 | a basement membrane | |
653 | a blood-brain barrier | |
653 | a central nervous system | |
653 | a embryonic development | |
653 | a endothelial cells | |
653 | a extracellular matrix | |
653 | a vasculature | |
653 | a basement membrane | |
653 | a blood-brain barrier | |
653 | a central nervous system | |
653 | a embryonic development | |
653 | a endothelial cells | |
653 | a extracellular matrix | |
653 | a vasculature | |
700 | 1 | a Hot, Belmau Karolinska Institute,Ludwig Institute for Cancer Research, Stockholm branch,Karolinska Inst, Sweden; Ludwig Inst Canc Res Ltd, Sweden4 aut |
700 | 1 | a Ramsköld, Danielu Karolinska Institutet,Karolinska Institute,Ludwig Institute for Cancer Research, Stockholm branch,Karolinska Inst, Sweden; Ludwig Inst Canc Res Ltd, Sweden4 aut |
700 | 1 | a Germano, Raoul F. V.u Université Libre de Bruxelles (ULB),Univ Libre Bruxelles, Belgium4 aut |
700 | 1 | a Yokota, Chikau Stockholm University,Stockholms universitet,Institutionen för biokemi och biofysik,Ludwig Institute for Cancer Research Ltd, Sweden,Ludwig Institute for Cancer Research, Stockholm branch,Ludwig Inst Canc Res Ltd, Sweden; Stockholm Univ, Sweden4 aut0 (Swepub:su)cyoka |
700 | 1 | a Giatrellis, Sarantisu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Lauschke, Volker M.u Karolinska Institutet,Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Hubmacher, Dirku Icahn School of Medicine at Mount Sinai,Icahn Sch Med Mt Sinai, NY 10029 USA4 aut |
700 | 1 | a Li, Minerva X.u Lund University,Lunds universitet,LUBIN Lab- Lunds laboratorium för neurokirurgisk hjärnskadeforskning,Forskargrupper vid Lunds universitet,LUBIN Lab- Lund Brain Injury laboratory for Neurosurgical research,Lund University Research Groups,Ludwig Institute for Cancer Research, Stockholm branch,Ludwig Inst Canc Res Ltd, Sweden; Lund Univ, Sweden4 aut0 (Swepub:lu)med-mvl |
700 | 1 | a Hupe, Mikeu Julius Maximilian University of Würzburg,Ludwig Institute for Cancer Research, Stockholm branch,Ludwig Inst Canc Res Ltd, Sweden; Univ Wurzburg, Germany4 aut |
700 | 1 | a Arnold, Thomas D.u University of California, San Francisco,Univ Calif San Francisco, CA 94143 USA4 aut |
700 | 1 | a Sandberg, Rickardu Karolinska Institutet,Karolinska Institute,Ludwig Institute for Cancer Research, Stockholm branch,Karolinska Inst, Sweden; Ludwig Inst Canc Res Ltd, Sweden4 aut |
700 | 1 | a Frisén, Jonasu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Trusohamn, Martau Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Martowicz, Agnieszkau Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Wisniewska-Kruk, Joannau Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Nyqvist, Danielu Karolinska Institutet,Karolinska Institute,Karolinska Inst, Sweden4 aut |
700 | 1 | a Adams, Ralf H.u University of Münster,Univ Munster, Germany4 aut |
700 | 1 | a Apte, Suneel S.u Cleveland Clinic Foundation,Cleveland Clin Fdn, OH 44195 USA4 aut |
700 | 1 | a Vanhollebeke, Benoitu Walloon Excellence in Life Sciences and Biotechnology,Université Libre de Bruxelles (ULB),Univ Libre Bruxelles, Belgium; Walloon Excellence Life Sci and Biotechnol WELBIO, Belgium4 aut |
700 | 1 | a Stenman, Jan M.u Ludwig Institute for Cancer Research, Stockholm branch,Ludwig Inst Canc Res Ltd, Sweden4 aut |
700 | 1 | a Kele, Juliannau Karolinska Institutet,Karolinska Institute,Ludwig Institute for Cancer Research, Stockholm branch,Karolinska Inst, Sweden; Ludwig Inst Canc Res Ltd, Sweden4 aut |
710 | 2 | a Linköping Universityb Avdelningen för kardiovaskulär medicin4 org |
773 | 0 | t Arteriosclerosis, Thrombosis and Vascular Biologyd : LIPPINCOTT WILLIAMS & WILKINSg 39:7, s. 1432-1447q 39:7<1432-1447x 1079-5642x 1524-4636 |
856 | 4 | u https://doi.org/10.1161/ATVBAHA.119.312388y Fulltext |
856 | 4 | u http://dx.doi.org/10.1161/ATVBAHA.119.312388x freey FULLTEXT |
856 | 4 | u https://liu.diva-portal.org/smash/get/diva2:1338183/FULLTEXT01.pdfx primaryx Raw objecty fulltext:print |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:su:diva-170819 |
856 | 4 8 | u https://doi.org/10.1161/ATVBAHA.119.312388 |
856 | 4 8 | u https://lup.lub.lu.se/record/dd004f7d-31a5-4193-ac94-3f225200bc62 |
856 | 4 8 | u https://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-158947 |
856 | 4 8 | u http://kipublications.ki.se/Default.aspx?queryparsed=id:141247867 |
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
Kopiera och spara länken för att återkomma till aktuell vy